Gulf Resources Inc. (GURE) shares continued to power higher on Monday, gaining 27%, after strong Q1 results reported Friday.
Shares of the manufacturer of specialty products in China rose to $2.26 per share Monday after gaining 11% after hours on Friday. The stock is trading near the top end of the 52-week spread between $1.04 and $3.20.
Net income was $4.3 million, or $0.11 per basic and diluted share, compared to $1.9 million, or $0.05 a year ago.
MannKind Posts Q1 Loss
MannKind (MNKD) shares were up 0.3% at $6.24 in pre-market trade Monday after it reported a Q1 loss.
The net loss applicable to common stockholders for Q1 2014 was $52.1 million, or $0.14 per share based on 368.8 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $41.0 million, or $0.15 per share based on 280.1 million weighted average shares outstanding for Q1 2013.
MNKD trades in a 52-week range of $3.80 to $8.70.
The Street estimates were not available.
Alnylam Pharmaceuticals Gains 8% as Hepatitis B Treatment Shows Promise on Chimpanzees
Alnylam Pharmaceuticals, Inc (ALNY) shares are up almost 8% pre-market after the company reported positive results from a trial of its ALN-HBV for the treatment of hepatitis B virus in chimpanzees.
“Alnylam’s new ALN-HBV program is a mature, pre-clinical asset acquired through the company’s acquisition of Sirna from Merck. We are very encouraged by the data we are presenting for the first time today, which we believe constitute the most robust proof-of-concept pre-clinical data to date with an RNAi therapeutic for the treatment of HBV,” said company vice president Laura Sepp-Lorenzino.
The stock recently traded at $58.50 and has moved in a 52-week range of $25.57 – $112.57.
3D Systems Higher in Pre-Bell – Inks Distribution Pact with ScanSource
3D Systems (DDD) is higher this morning after it announced a partnership with ScanSource (SCSC) to collaborate on the sale and support of 3D printing solutions. No financial terms were disclosed.
Peabody Energy Upgraded to Overweight at Morgan Stanley, PT Raised $10 to $30; Shares Spike 4% Early
Peabody Energy Corporation (BTU) has been upgraded by Morgan Stanley to an overweight rating from an equalweight rating.
The firm also boosted the price target on shares of the private sector coal company by 50% to $30 from $20.
In pre-market activity, shares of BTU are up 3.75% to $19.36, and have a 52-week trading range of $14.34 – $21.84.
Vectren Corporation Q1 Earnings Miss Views While Sales Easily Beat Estimates
Vectren Corporation (VVC) reported Q1 earnings that missed analysts’ expectations even as sales were well ahead of estimates.
VCC traded lower 0.4%, in the upper half of the 52-week range between $31.83 and $41.14.
The owner of among others public utlities said its Q1 earnings rose modestly to $51.2 million or $0.62 per share from $49.8 million or $0.61 per share amid higher operating expenses. Analysts polled by Capital IQ had expected EPS of $0.74 per share. Sales were $796.8 million compared to $700.6 million a year ago, exceeding the $750 million average estimate.
“We fully expect that the infrastructure services work that was delayed in the first quarter as a result of the weather, along with other work, will be largely completed over the remainder of the year as there continues to be very high demand for those services,” CEO Carl Chapman said in a statement.
Vectren reaffirmed its FY14 guidance of consolidated earnings between $2.15 and $2.35 per share compared to the $2.27 average estimate from analysts polled by Capital IQ.
Core Laboratories Drops 12% Pre-Bell After Cutting 2014 EPS, Revenue Guidance
Core Laboratories (CLB) shares are down more than 12% after the company cut its 2014 revenue and earnings guidance after an unexpectedly weak performance in April.
Core, which provides reservoir management services to the oil and gas industry, expects Q2 2014 EPS to be in the $1.32 – 1.35 range with revenue ranging from $265 million to $270 million.
Analysts were looking for Q2 EPS of $1.51 on revenue of $285 million.
Full year EPS is expected to range from $5.80 to $6.00 with revenue of approximately $1.1 billion. That’s below the consensus forecast for EPS of $6.20 and revenue of $1.2 billion.
The shares recently traded at $166.00 in a 52-week range of $133.02 – $221.00
Analyst Actions: Intersil Up 3% on Citigroup Upgrade to Neutral from Sell
Intersil (ISIL) shares were up 3% at $13.15 late in Friday’s session after shares were upgraded to Neutral from Sell at Citigroup, which has a $14 price target.
Intersil manufactures and markets analog, mixed-signal, and power management integrated circuits.
ISIL trades in a 52-week range of $7.28 to $13.58.
Chefs’ Warehouse Files to Announce Late Earnings – Stock Down 3%
The Chefs’ Warehouse, Inc. (CHEF), a distributor of specialty food products, said it filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with the company’s Quarterly Report on Form 10-Q for the quarter ended March 28, 2014. The Company’s quarterly report was due on May 7, 2014.
Based on information the Company reviewed as part of the procedures for preparing the report on Form 10-Q for the quarter ended March 28, 2014, the Company has determined that the accrual for accounts payable at its Michael’s Finer Meats subsidiary may have been understated at quarter end by approximately $786,000. The Company is in the process of finalizing a detailed review of the accounts payable accrual and anticipates that it will file the report on Form 10-Q no later than five calendar days from the date that it was due. The effect of an understatement of the accrual for accounts payable by that amount would result in a reduction to net income by approximately $460,000 and net income per share by approximately $0.02 per share from the results that the Company preliminarily reported on May 1, 2014.
The impact of the accrual does not affect the Company’s previously issued financial guidance for fiscal year 2014.
Molycorp Slips 19% on Downgrade to Underweight from Neutral at JPMorgan Chase
Molycorp (MCP) shares plunged 19% in Friday’s session, hitting a 52-week low of $3.01, as shares were downgraded to Underweight from Neutral at JPMorgan Chase & Co.
It’s the second day of declines for Molycorp. Shares traded about 18% lower Thursday after reporting a bigger than expected loss for Q1.
Erickson Swings to Adjusted Q1 Loss – Stock Drops 5%
Helicopter manufacturer Erickson Inc. (EAC) drops nearly 5% Friday after swinging to an adjusted loss from a narrow profit a year earlier.
EAC reported a Q1 net loss of $7.6 million, or $0.55 per diluted share, as compared to a net loss of $1.2 million, or $0.13 per diluted share in the prior year’s Q1. The company’s adjusted net loss was $7.1 million, or $0.52 per diluted share compared to a profit of $0.01 in the same period a year earlier. Analyst estimates were not available.
The stock neared a test of its $14.10 52-week low.
Shire Edges Up Pre-Bell Following Lumena Pharmaceuticals Buy
American Depositary Shares of Shire (SHPG) edged up 0.3% in recent pre-market trading on Monday, following the biopharmaceutical company’s acquisition of Lumena Pharmaceuticals, a company with late stage rare disease pipeline assets.
SHPG will acquire Lumena for an upfront payment of $260 million in cash, plus a payment for net cash at closing, and near-term contingent milestone payments related to ongoing clinical trials. It does not expect the acquisition of Lumena to result in a change to its previously stated earnings guidance for 2014.
SHPG closed at $168.15 Friday, in a 52-week range of $91.81 – $180.91.
Gogo Inc. Reports Narrower Loss, Beats Street on Revenues; Shares Up Nearly 5% Pre-Bell
Gogo Inc. (GOGO) has reported a Q1 loss per share of $0.20, narrower than the loss of $4.77 per share in Q1 2013 and the $0.25 per share predicted by analysts for Q1 2014. Total revenue of $95.7 million was up from $70.8 million in Q1 2013 and beat analyst estimates of $94.03 million.
The company has reaffirmed full-year guidance of total revenue of $400 million to $422 million. The Street is at $413 million.
“We expect continued strong growth in revenue fueled by strong secular trends and passenger adoption of new services,” said President and CEO Michael Small. “We continue to add capacity by upgrading aircraft to ATG-4 technology and had 534 aircraft equipped with ATG-4 systems at the end of March. We expect to see significant capacity increases with the introduction of our GTO and 2Ku airborne antennas, both of which are capable of delivering industry leading speeds of 70 mbps to the aircraft initially, and up to 100 mbps when spot beam Ku satellites are launched.”
Shares of GOGO are up $0.57, or 4.78%, at $12.50 in pre-market trading with a 52-week range of $9.71 – $35.77.
Orange Down 1% Despite Upgrade to Neutral From Sell at UBS
Orange (ORAN) shares were down about 1% in Friday’s session even after shares were upgraded to neutral from sell at UBS.
ORAN trades in a 52-week range of $9.10 to $16.86, trading close to the top end of that range. Shares hit a session low of $16.43 before climbing for most of the session.
Amgen, AstraZeneca Achieve Positive Results in Phase 3 Study of Psoriasis Treatment
Amgen (AMGN) and AstraZeneca (AZN) report that their phase 3 AMAGINE-1TM study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis met all primary and secondary endpoints for both evaluated doses. Primary endpoints were patients achieving at least a 75% improvement from baseline in disease severity at week 12, as measured by the Psoriasis Area Severity Index (PASI 75), and patients achieving clear or almost clear skin at week 12 according to the static Physician Global Assessment.
Shares of both companies are flat in after-hours trade.
AIG Narrows CEO Candidates to Top 2 – Shares Down 2.5% in First Pre-Market Matches
AIG (AIG) has narrowed its search for its next CEO to succeed Robert Benmosche to two of its executives, Peter Hancock and Jay Wintrob, according to Dow Jones Newswires.
Hancock runs the global property-casualty business while Wintrob runs the life-insurance and retirement business.
AIG trades in a 52-week range of $41.53 to $53.33.
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »
